Literature DB >> 17148989

Pigmented villonodular synovitis.

William M Mendenhall1, Charles M Mendenhall, John D Reith, Mark T Scarborough, C Parker Gibbs, Nancy P Mendenhall.   

Abstract

Pigmented villonodular synovitis (PVNS) is a rare proliferative disorder that affects the synovium in young and middle-aged adults. Although most believe that it is an inflammatory process, some believe that it is a benign neoplasm. The optimal treatment is surgery. The local recurrence rate after marginal excision for localized PVNS is low. In contrast, the local recurrence rate after open synovectomy for diffuse PVNS is relatively high. The intra-articular instillation of radioactive isotopes or external beam radiotherapy (approximately 35 Gy in 14-15 fractions over 3 weeks) may significantly improve the likelihood of local control and long-term function in patients with incompletely resected diffuse PVNS. The probability of complications after moderate-dose radiotherapy (RT) is low.

Entities:  

Mesh:

Year:  2006        PMID: 17148989     DOI: 10.1097/01.coc.0000239142.48188.f6

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  14 in total

1.  Orthopaedic case of the month: Painless right knee mass in 32-year-old man.

Authors:  Michael K Merz; Mansooreh Eghtesadghalati; Michael E Bresler; Yasser R Farid
Journal:  Clin Orthop Relat Res       Date:  2012-09-12       Impact factor: 4.176

2.  Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates?

Authors:  Matthew W Colman; Jason Ye; Kurt R Weiss; Mark A Goodman; Richard L McGough
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

3.  [The indication for radiosynoviorthesis. From the perspective of the nuclear medicine expert, rheumatic orthopedist and internist].

Authors:  R Linke; K Gelse; F Schuch
Journal:  Z Rheumatol       Date:  2011-01       Impact factor: 1.372

4.  "A 40-year-old female with painless, slow growing prepatellar mass".

Authors:  Sumit Arora; Sahil Batra; Seema Rao; Lalit Maini; V K Gautam
Journal:  J Clin Orthop Trauma       Date:  2014-09-29

5.  MRI diagnosis of recurrent pigmented villonodular synovitis following total joint arthroplasty.

Authors:  Talia Friedman; Timothy Chen; Anthony Chang
Journal:  HSS J       Date:  2012-08-28

6.  An unusual presentation of peroneal neuropathy secondary to pigmented villonodular synovitis: a case report.

Authors:  Zafer Orhan; Birhan Oktas; Umran Yildirim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-02-10       Impact factor: 4.342

Review 7.  Targeted therapies: the rare cancer paradigm.

Authors:  Marco A Pierotti; Tiziana Negri; Elena Tamborini; Federica Perrone; Sabrina Pricl; Silvana Pilotti
Journal:  Mol Oncol       Date:  2009-10-28       Impact factor: 6.603

8.  Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.

Authors:  Laura Mangiavini; Christophe Merceron; Elisa Araldi; Richa Khatri; Rita Gerard-O'Riley; Tremika L Wilson; George Sandusky; Jerome Abadie; Karen M Lyons; Amato J Giaccia; Ernestina Schipani
Journal:  Am J Pathol       Date:  2015-09-06       Impact factor: 4.307

9.  Correlation between equivalent cross-relaxation rate and cellular density in soft tissue tumors.

Authors:  Shunsuke Hamada; Shigeru Matsushima; Hideshi Sugiura; Kenji Yamada; Yoshihiro Nishida; Naoki Ishiguro
Journal:  Skeletal Radiol       Date:  2013-11-20       Impact factor: 2.199

Review 10.  Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis.

Authors:  Mehdi Brahmi; Armelle Vinceneux; Philippe A Cassier
Journal:  Curr Treat Options Oncol       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.